Author

Biogen Inc.

Kidney Transplantation
Starts phase 3 study of ferusaltamab for the treatment of late antibody-mediated rejection (AMR) in renal transplant patients

by Biogen Inc. March 24, 2025

by Biogen Inc. March 24, 2025

Biogen Inc. Global Phase 3 Overlap Study Evaluates the Efficacy and Safety of Ferzaltamab compared to placebo in adults with delayed AMR AMR is the main cause of kidney transplant …

Welcome to Daily Transplant News, your trusted source for the latest updates, stories, and information on transplantation and organ donations. We are passionate about sharing the inspiring journeys, groundbreaking research, and invaluable resources surrounding the world of transplantation.

Useful Links

Most Viewed Articles

Fox NewsRFK Jr. calls for reforms to the practices of the organ donation...

Teens go viral after receiving two liver transplants (exclusive)

Legislation attached for families of young NS women in ICU after a second...

Latest Articles

The Power of Yes – Organ Donation Myths vs. Facts

Journey of the Heart | 19-Year-Old Organ Donor Saves Life | UW Health Transplant Program

Specialist Nurse Organ Donation

Organ & Body Donations: Last Week Tonight with John Oliver (HBO)

Are you sure want to unlock this post?

Unlock left : 0

Are you sure want to cancel subscription?

Show/Hide Player

00:00

Queue

Update Required Flash plugin

00:00